Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelium | 1 | 2008 | 71 | 0.290 |
Why?
|
| Cell Communication | 1 | 2008 | 188 | 0.280 |
Why?
|
| Endothelial Cells | 3 | 2013 | 544 | 0.230 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 1051 | 0.230 |
Why?
|
| Signal Transduction | 3 | 2013 | 4934 | 0.170 |
Why?
|
| Aortic Valve | 1 | 2024 | 469 | 0.170 |
Why?
|
| Cell Lineage | 2 | 2013 | 370 | 0.150 |
Why?
|
| Stem Cells | 2 | 2013 | 754 | 0.130 |
Why?
|
| Genes, Reporter | 2 | 2009 | 398 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2015 | 47 | 0.120 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2015 | 56 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2013 | 65 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 62 | 0.110 |
Why?
|
| Endothelium, Lymphatic | 1 | 2013 | 10 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 80 | 0.100 |
Why?
|
| Aldehyde Oxidoreductases | 2 | 2013 | 20 | 0.100 |
Why?
|
| Tretinoin | 2 | 2013 | 118 | 0.100 |
Why?
|
| Regenerative Medicine | 1 | 2011 | 37 | 0.090 |
Why?
|
| Cell Differentiation | 3 | 2013 | 2045 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 522 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 564 | 0.080 |
Why?
|
| Genetic Techniques | 1 | 2009 | 109 | 0.070 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2007 | 20 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 2137 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2008 | 231 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 1007 | 0.060 |
Why?
|
| Heterozygote | 1 | 2008 | 728 | 0.060 |
Why?
|
| Time Factors | 2 | 2024 | 6610 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2008 | 837 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 897 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 1433 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 1417 | 0.060 |
Why?
|
| Models, Biological | 1 | 2008 | 1539 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 2539 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 1761 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 2 | 2013 | 228 | 0.040 |
Why?
|
| Reoperation | 1 | 2024 | 856 | 0.040 |
Why?
|
| Aortic Valve Stenosis | 1 | 2024 | 360 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 2947 | 0.040 |
Why?
|
| Animals | 5 | 2015 | 36557 | 0.040 |
Why?
|
| Mice | 3 | 2015 | 19055 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2024 | 1096 | 0.040 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2024 | 1163 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 323 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 237 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2013 | 7 | 0.030 |
Why?
|
| Embryo Culture Techniques | 1 | 2013 | 25 | 0.030 |
Why?
|
| Lac Operon | 1 | 2013 | 96 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2013 | 62 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2013 | 40 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2013 | 2563 | 0.030 |
Why?
|
| Lentivirus | 1 | 2013 | 87 | 0.030 |
Why?
|
| Lymphangiogenesis | 1 | 2013 | 18 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 1107 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 311 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 915 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2024 | 3178 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8623 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 79 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 178 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 2218 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 11182 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2009 | 198 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 13240 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2009 | 183 | 0.020 |
Why?
|
| United States | 1 | 2024 | 11763 | 0.020 |
Why?
|
| Humans | 6 | 2024 | 134156 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 13074 | 0.020 |
Why?
|
| Male | 3 | 2024 | 66127 | 0.020 |
Why?
|
| Female | 3 | 2024 | 71928 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 1096 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2007 | 95 | 0.020 |
Why?
|
| K562 Cells | 1 | 2007 | 100 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2009 | 628 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 703 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 17540 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 672 | 0.020 |
Why?
|
| Plasmids | 1 | 2007 | 529 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 4016 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2009 | 970 | 0.010 |
Why?
|
| Gene Expression | 1 | 2009 | 1621 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 2864 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 1853 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 2738 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 3180 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 3043 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 7570 | 0.010 |
Why?
|